Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study.
Zaballa ME, Perez-Saez J, de Mestral C, Pullen N, Lamour J, Turelli P, Raclot C, Baysson H, Pennacchio F, Villers J, Duc J, Richard V, Dumont R, Semaani C, Loizeau AJ, Graindorge C, Lorthe E, Balavoine JF, Pittet D, Schibler M, Vuilleumier N, Chappuis F, Kherad O, Azman AS, Posfay-Barbe KM, Kaiser L, Trono D, Stringhini S, Guessous I; Specchio-COVID19 study group. Zaballa ME, et al. Among authors: kherad o. Lancet Reg Health Eur. 2023 Jan;24:100547. doi: 10.1016/j.lanepe.2022.100547. Epub 2022 Dec 1. Lancet Reg Health Eur. 2023. PMID: 36474728 Free PMC article.
Occupational risk of SARS-CoV-2 infection and reinfection during the second pandemic surge: a cohort study.
Leidi A, Berner A, Dumont R, Dubos R, Koegler F, Piumatti G, Vuilleumier N, Kaiser L, Balavoine JF, Trono D, Pittet D, Chappuis F, Kherad O, Courvoisier DS, Azman AS, Zaballa ME, Guessous I, Stringhini S; SEROCoV-WORK+ study group. Leidi A, et al. Among authors: kherad o. Occup Environ Med. 2022 Feb;79(2):116-119. doi: 10.1136/oemed-2021-107924. Epub 2021 Dec 8. Occup Environ Med. 2022. PMID: 34880045
Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological study.
Dumont R, Nehme M, Lorthe E, De Mestral C, Richard V, Baysson H, Pennacchio F, Lamour J, Semaani C, Zaballa ME, Pullen N, Perrin A, L'Huillier AG, Posfay-Barbe KM, Guessous I, Stringhini S; Specchio-COVID19 study group. Dumont R, et al. BMJ Open. 2022 Nov 21;12(11):e063504. doi: 10.1136/bmjopen-2022-063504. BMJ Open. 2022. PMID: 36410813 Free PMC article.
Impact of the COVID-19 pandemic on children and adolescents: determinants and association with quality of life and mental health-a cross-sectional study.
Richard V, Dumont R, Lorthe E, Loizeau A, Baysson H, Zaballa ME, Pennacchio F, Barbe RP, Posfay-Barbe KM, Guessous I, Stringhini S; SEROCoV-KIDS Study Group. Richard V, et al. Child Adolesc Psychiatry Ment Health. 2023 Feb 1;17(1):17. doi: 10.1186/s13034-023-00563-5. Child Adolesc Psychiatry Ment Health. 2023. PMID: 36726179 Free PMC article.
Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection.
Perez-Saez J, Zaballa ME, Lamour J, Yerly S, Dubos R, Courvoisier DS, Villers J, Balavoine JF, Pittet D, Kherad O, Vuilleumier N, Kaiser L, Guessous I, Stringhini S, Azman AS; Specchio-COVID19 study group. Perez-Saez J, et al. Among authors: kherad o. Nat Commun. 2023 May 26;14(1):3032. doi: 10.1038/s41467-023-38744-7. Nat Commun. 2023. PMID: 37230973 Free PMC article.
Socioeconomic conditions and children's mental health and quality of life during the COVID-19 pandemic: An intersectional analysis.
Lorthe E, Richard V, Dumont R, Loizeau A, Perez-Saez J, Baysson H, Zaballa ME, Lamour J, Pullen N, Schrempft S, Barbe RP, Posfay-Barbe KM, Guessous I, Stringhini S; SEROCoV-KIDS study group. Lorthe E, et al. SSM Popul Health. 2023 Jul 23;23:101472. doi: 10.1016/j.ssmph.2023.101472. eCollection 2023 Sep. SSM Popul Health. 2023. PMID: 37560087 Free PMC article.
[Vitamin D intoxication and "milk alkali syndrome"].
Bovet L, Roth L, Kherad O. Bovet L, et al. Among authors: kherad o. Rev Med Suisse. 2024 Feb 14;20(861):360-362. doi: 10.53738/REVMED.2024.20.861.360. Rev Med Suisse. 2024. PMID: 38353439 French.
Do you speak français ?
Kherad O. Kherad O. Rev Med Suisse. 2023 Nov 8;19(849):2132. doi: 10.53738/REVMED.2023.19.849.2132. Rev Med Suisse. 2023. PMID: 37938313 French. No abstract available.
112 results